In Japan, sales of Eisai and Biogen’s Alzheimer’s drug begin to accelerate

Bio­gen and Ei­sai’s Alzheimer’s drug Leqem­bi is off to a slow start in the US. But it’s big in Japan.

On Fri­day, Ei­sai re­vealed in …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.